Tumor protein vaccine prophylactic trials are designed to examine whether the vaccine's targets are directed against a wide range of antigens, can cover 90% or even 100% of patients with different tumor subtypes as well as whether they can boost the body's immune system before tumors form.
For more product details, please visit Aladdin Scientificwebsite.
Was this article helpful?YesNo2 out 3 found this helpful
We use cookies to ensure the website functions properly and, where permitted, to improve your experience. You can manage your preferences at any time in Settings. Learn more in our Cookie Policy.
Shall we send you a message when we have discounts available?
Remind me later
Thank you! Please check your email inbox to confirm.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.
